Esthesioneuroblastoma - What is the optimal treatment?

Acta Oncologica

Volumn 39, Issue 2, 2000, Pages 231-235

  Eriksen, Jesper G ^a   Bastholt, Lars ^a   Krogdahl, Annelise S ^a   Hansen, Olfred ^a   Joergensen, Karsten E ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; ESTHESIONEUROBLASTOMA; FEMALE; HUMAN; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0034108031     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418600430833     Document Type: Article

References (33)

1. Nelson RS, Pearlman EJ, Askin F. Is esthesioneuroblastoma a peripheral neuroectodermal tumor? Hum Pathol 1995; 26: 639-41.
2. Broich G, Pagliari A, Ottaviani F. Esthesioneuroblastoma: a general review of the disease published since the discovery of the tumor in 1924. Anticancer Research 1997; 17: 2683-706.
3. Svane-Knudsen V, Joergensen KE, Hansen O, Lindgren A, Marker P. Cancer of the nasal cavity and paranasal sinuses: a series of 115 patients. Rhinology 1998; 36: 12-4.
4. Kadish S, Goodman M, Wang CC. Olfactory neuroblastoma: a clinical analysis of 17 cases. Cancer 1976; 37: 1571-6.
5. Morita A, Ebersold MJ, Olsen KD, Foote RL, Lewis JE, Quast LM. Esthesioneuroblastoma: prognosis and management. Neurosurgery 1993; 32: 706-15.
6. Elkon D, Hightower SI, Lim ML, Cantrell RW, Constable WC. Esthesioneuroblastoma. Cancer 1979; 44: 1087-94.
7. Dulguerov P, Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992; 102: 843-9.
8. Spaulding CA, Kranyak MS, Constable WC, Stewart FM. Esthesioneuroblastoma: a comparison of two treatment eras. Int J Radiat Oncol Biol Phys 1988; 15: 581-90.
9. Foote RL, Morita A, Ebersold MJ, et al. Esthesioneuroblastoma: the role of adjuvant radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27: 835-42.
10. Eden BV, Debo RF, Larner JM, et al. Esthesioneuroblastoma - long term outcome and patterns of failure - the University of Virginia experience. Cancer 1994; 73: 2556-62.
11. Beitler JJ, Fass DE, Brenner HA, et al. Esthesioneuroblastoma: is there a role for elective neck treatment? Head Neck 1991; Jul/Aug: 321-6.
12. Hirose T, Scheithauer BW, Lopes MBS, et al. Olfactory neuroblastoma - an immunohistochemical, ultrastructural and flow cytometric study. Cancer 1995; 76: 4-19.
13. Wong WS, Tattersall MH. Immunohistochemical determination of tumor growth fraction in human ovarian tumors. Br J Obstet Gynaecol 1989; 96: 720-4.
14. Gasparini G, Pozza F, Meli S, Reitano M, Bevilacqua P. Breast cancer kinetics: immunocytochemical determination of growth fractions by monoclonal antibody KI-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness. Anticancer Res 1991; 11: 2015-21.
15. Shaari CM, Catalano PJ, Sen C, Post K. Central nervous system metastases from esthesioneuroblastoma. Otolaryngol Head Neck Surg 1996; 114: 808-12.
16. Guedea F, Van Limbergen E, Van Den Bogaert W. High dose level radiation therapy for local tumor control in esthesioneuroblastoma. Eur J Cancer 1994; 30A: 1757-60.
17. Jekunen AP, Kairemo KJA, Lehtonen HP, Kajanti MJ. Treatment of olfactory neuroblastoma - a report of 11 cases. Am J Clin Oncol 1996; 19: 375-8.
18. Homize MJ, Elkon D. Olfactory esthesioneuroblastoma - variables predictive of tumor control and recurrence. Cancer 1980; 46: 2509-13.
19. McCaffrey TV, Olsen KD, Yohanan JM, Lewis JE, Ebersold MJ, Piepgras DG. Factors affecting survival of patients with tumors of the anterior skull base. Laryngoscope 1994; 104: 940-5.
20. Kempf HG, Becker G, Weber PD, Ruck P. Diagnostik und therapie des Olfaktoriusneuroblastoms. HNO 1994; 42: 422-8.
21. Feyerabend T. Die stellung der radiotherapie in der behandlung des aesthesioneuroblastoms. HNO 1990; 38: 20-3.
22. Bhattacharyya N, Thornton A, Joseph MP, Goodman ML, Amrein PC. Successful treatment of esthesioneuroblastoma and neuroendocrine carcinoma with combined chemotherapy and proton radiation. Arch Otol Head Neck Surg 1997; 123: 34-40.
23. Million RR, Cassisi NJ. Management of Head and Neck Cancer. 2nd ed. Philadelphia: JB Lippencott Co. 1994: 575-86.
24. Levine PA, Debo RF, Meredith SD, Jane JA, Constable WC, Cantrell RW. Craniofacial resection at the University of Virginia (1976-1992): survival analysis. Head Neck 1994; Nov-Dec: 574-7.
25. Goldsweig HG, Sundaresan N. Chemotherapy of recurrent esthesioneuroblastoma - case report and review of the literature. Am J Clin Oncol 1990; 13: 39-43.
26. Jacob HE. Chemotherapy for cranial base tumors. J Neuro Oncol 1994; 20: 327-35.
27. Levine PA, McLean WC, Cantrell RW. Esthesioneuroblastoma: the University of Virginia experience 1960-1985. Laryngoscope 1986; 96: 742-6.
28. Zaleska-Czepko E, Cwiklinska M, Balwierz W, Armata J. Successful multidrug chemotherapy of olfactory neuroblastoma in a 8-year-old child. Ped Haematol Oncol 1996; 13: 191-3.
29. Stewart FM, Lazarus HM, Levine PA, Stewart KA, Tabbara IA, Spaulding CA. High-dose chemotherapy and autologous marrow transplantation for esthesioneuroblastoma and sinonasal undifferentiated carcinoma. Am J Clin Ocol 1989; 12: 217-21.
30. Newbill ET, Johns ME, Cantrell RW. Esthesioneuroblastoma - diagnosis and management. South Med J 1985; 78: 275-82.
31. Shah JP, Feghali J. Esthesioneuroblastoma. CA-A Cancer J Clin 1983; 33: 154-9.
32. Spiro JD, Soo KC, Spiro RH, Nonsquamous cell malignant neoplasms of the nasal cavities and paranasal sinuses. Head Neck 1995; March/April: 114-8.
33. Strnad V, Grabenbauer GG, Dunst J, Sauer R. Radiotherapie beim aesthesioneuroblastom. Strahlenther Onkol 1994; 170: 79-84.